ADx NeuroSciences partners with Alamar Biosciences to advance neurodegenerative assays
Biospace - 28-Oct-2024Together, they aim to provide pharmaceutical companies with precise tools for drug development
Join the club for FREE to access the whole archive and other member benefits.
Proteomics company
Alamar Biosciences specializes in precision proteomics, offering automated, high-throughput solutions for ultra-sensitive protein analysis across various multiplex levels. Their proprietary NULISA™ Chemistry employs a unique sequential capture and release method, enhancing sensitivity and dynamic range by minimizing background signal. This method supports both qPCR and NGS readouts. Alamar’s NULISAseq Inflammation Panel includes over 200 markers associated with immune and inflammatory diseases, running on the ARGO™ System. This platform enables a fully automated workflow with less than 30 minutes of hands-on time, allowing researchers to efficiently obtain data from sample to result.
Visit website: https://alamarbio.com/
Details last updated 13-Nov-2024
Together, they aim to provide pharmaceutical companies with precise tools for drug development